Evidence map›Paper›PMID 31547470›Full record

ArticleMicroorganisms2019

Vδ2 T-Cells Kill ZIKV-Infected Cells by NKG2D-Mediated Cytotoxicity.

Eleonora Cimini, Alessandra Sacchi, Sara De Minicis, Veronica Bordoni, Rita Casetti, Germana Grassi, Francesca Colavita, Concetta Castilletti, Maria Rosaria Capobianchi, Giuseppe Ippolito and 3 more

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Eleonora CiminiImmunology and Pharmacology Laboratory, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, via Portuense 292, 00149 Rome, Italy. eleonora.cimini@inmi.it.
Alessandra SacchiImmunology and Pharmacology Laboratory, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, via Portuense 292, 00149 Rome, Italy. alessandra.sacchi@inmi.it.
Sara De MinicisImmunology and Pharmacology Laboratory, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, via Portuense 292, 00149 Rome, Italy. demsara@hotmail.it.
Veronica BordoniImmunology and Pharmacology Laboratory, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, via Portuense 292, 00149 Rome, Italy. veronica.bordoni@inmi.it.
Rita CasettiImmunology and Pharmacology Laboratory, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, via Portuense 292, 00149 Rome, Italy. rita.casetti@inmi.it.
Germana GrassiImmunology and Pharmacology Laboratory, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, via Portuense 292, 00149 Rome, Italy. germana.grassi@inmi.it.
Francesca ColavitaVirology Laboratory, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, via Portuense 292, 00149 Rome, Italy. francesca.colavita@inmi.it.ORCID 0000-0003-0640-8667
Concetta CastillettiVirology Laboratory, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, via Portuense 292, 00149 Rome, Italy. concetta.castilletti@inmi.it.ORCID 0000-0001-9819-236X
Maria Rosaria CapobianchiVirology Laboratory, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, via Portuense 292, 00149 Rome, Italy. maria.capobianchi@inmi.it.
Giuseppe IppolitoScientific Direction; National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, via Portuense 292, 00149 Rome, Italy. giuseppe.ippolito@inmi.it.ORCID 0000-0002-1076-2979
Maria Giovanna DesimioDivision of Immunology and Infectious Diseases, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Piazza Sant'Onofrio 4, 00165 Rome, Italy. doria@uniroma2.it.
Margherita DoriaDivision of Immunology and Infectious Diseases, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Piazza Sant'Onofrio 4, 00165 Rome, Italy. mariagiovanna.dsm@gmail.com.ORCID 0000-0001-5533-0304
Chiara AgratiImmunology and Pharmacology Laboratory, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, via Portuense 292, 00149 Rome, Italy. chiara.agrati@inmi.it.
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITBambino Gesù Children's Hospital · IT

Funding

Ministero della Salute GR-2016-02362110Ministero della Salute RF-2016-02363642Ministero della Salute RF-2016-02364155Ministero della Salute Ricerca Corrente Linea 1
6 · The paper itself

Abstract

An expansion of effector/activated Vδ2 T-cells was recently described in acute Zika virus (ZIKV)-infected patients, but their role in the protective immune response was not clarified. The aim of this study was to define the antiviral activity of Vδ2 T-cells against ZIKV-infected cells. The Vδ2 T-cells expansion and their cytotoxic activity against ZIKV-infected cells were tested

Indexed as

antiviral activitycytotoxicityinnate immunityNKG2DperforinVδ2 T-cellsZIKV

Identifiers

PMID31547470
PMCPMC6781265
OpenAlexW2972851360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.